FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3161231545> ?p ?o ?g. }

• W3161231545 endingPage "1830" @default.
• W3161231545 startingPage "1821" @default.
• W3161231545 abstract "Electronic nicotine delivery systems (ENDS) may improve public health if they facilitate smokers switching away from cigarettes. Conceptually, switching is facilitated when ENDS provide adequate nicotine delivery. Switching rates among smokers who purchased the JUUL System (JUUL) were compared in the United Kingdom (UK), where regulations limit nicotine concentration to 20 mg/mL versus North America (N.Am.; United States and Canada), where higher concentrations are available.Adult established smokers (age ≥21, smoked ≥100 cigarettes, smoking some days or every day at baseline) who newly purchased JUUL were recruited into a longitudinal study (UK: N = 1247; N.Am.: N = 8835). Complete switching (no smoking for ≥30 days) was assessed 1, 3, and 6 months after purchase; propensity score matching (PSM) and logistic regression compared switching after adjusting for baseline characteristics.In both N.Am. and UK, ≥82% of participants reported using the highest JUUL nicotine concentration available (UK: 18 mg/mL; N.Am.: 59 mg/mL). Unadjusted switching rates did not differ at 1 month (17%-18%); unadjusted and adjusted rates were significantly higher in N.Am. (vs. UK) at 3 and 6 months. In the PSM sample, after additional covariate adjustment, rates were significantly higher in N.Am. (vs. UK) at 3 months (31.5% vs. 22.7%; odds ratio [95% confidence interval, CI] = 1.59 [1.25, 2.02]) and 6 months (38.0% vs. 26.0%; odds ratio [95% CI] = 1.79 [1.37, 2.35]).These results suggest availability of ENDS in nicotine concentrations greater than 20 mg/mL may be associated with increased switching among adult smokers. Differences in smoking and ENDS use characteristics did not explain associations of location and switching; however, between-country differences may be affected by unmeasured factors.Switching rates were lower among smokers who purchased the JUUL System (JUUL) in the UK, where regulations limit nicotine concentration to 20 mg/mL versus N.Am. (United States and Canada), where higher concentrations are available-before and after controlling for differences in smoking and ENDS use characteristics. These results suggest availability of ENDS in nicotine concentrations greater than 20 mg/mL may be associated with increased switching among adult smokers. Between-country differences may be affected by unmeasured factors; future research should consider these factors and the extent to which regulatory policy environments may explain differences in switching among adult smokers." @default.
• W3161231545 created "2021-05-24" @default.
• W3161231545 creator A5017004560 @default.
• W3161231545 creator A5035371265 @default.
• W3161231545 creator A5037281835 @default.
• W3161231545 creator A5039890834 @default.
• W3161231545 creator A5049543546 @default.
• W3161231545 creator A5077585559 @default.
• W3161231545 date "2021-05-18" @default.
• W3161231545 modified "2023-10-16" @default.
• W3161231545 title "Differences in Switching Away From Smoking Among Adult Smokers Using JUUL Products in Regions With Different Maximum Nicotine Concentrations: North America and the United Kingdom" @default.
• W3161231545 cites W2009119212 @default.
• W3161231545 cites W2058393133 @default.
• W3161231545 cites W2120278397 @default.
• W3161231545 cites W2121690051 @default.
• W3161231545 cites W2137599927 @default.
• W3161231545 cites W2150291618 @default.
• W3161231545 cites W2167489015 @default.
• W3161231545 cites W2258296723 @default.
• W3161231545 cites W2320977910 @default.
• W3161231545 cites W2333354113 @default.
• W3161231545 cites W2735301415 @default.
• W3161231545 cites W2747050788 @default.
• W3161231545 cites W2753294463 @default.
• W3161231545 cites W2783256295 @default.
• W3161231545 cites W2799782697 @default.
• W3161231545 cites W2810946886 @default.
• W3161231545 cites W2884928432 @default.
• W3161231545 cites W2887933045 @default.
• W3161231545 cites W2889528655 @default.
• W3161231545 cites W2912583888 @default.
• W3161231545 cites W2913337886 @default.
• W3161231545 cites W2914585126 @default.
• W3161231545 cites W2922790973 @default.
• W3161231545 cites W2962551685 @default.
• W3161231545 cites W2972036070 @default.
• W3161231545 cites W2985399868 @default.
• W3161231545 cites W3008212934 @default.
• W3161231545 cites W3019448998 @default.
• W3161231545 cites W3037284250 @default.
• W3161231545 cites W3045306166 @default.
• W3161231545 cites W3084014714 @default.
• W3161231545 cites W3089164724 @default.
• W3161231545 cites W3096265380 @default.
• W3161231545 cites W3106792857 @default.
• W3161231545 cites W3116044730 @default.
• W3161231545 cites W3124026803 @default.
• W3161231545 cites W3158226936 @default.
• W3161231545 cites W4237795005 @default.
• W3161231545 doi "https://doi.org/10.1093/ntr/ntab062" @default.
• W3161231545 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34002223" @default.
• W3161231545 hasPublicationYear "2021" @default.
• W3161231545 type Work @default.
• W3161231545 sameAs 3161231545 @default.
• W3161231545 citedByCount "9" @default.
• W3161231545 countsByYear W31612315452021 @default.
• W3161231545 countsByYear W31612315452022 @default.
• W3161231545 countsByYear W31612315452023 @default.
• W3161231545 crossrefType "journal-article" @default.
• W3161231545 hasAuthorship W3161231545A5017004560 @default.
• W3161231545 hasAuthorship W3161231545A5035371265 @default.
• W3161231545 hasAuthorship W3161231545A5037281835 @default.
• W3161231545 hasAuthorship W3161231545A5039890834 @default.
• W3161231545 hasAuthorship W3161231545A5049543546 @default.
• W3161231545 hasAuthorship W3161231545A5077585559 @default.
• W3161231545 hasBestOaLocation W31612315451 @default.
• W3161231545 hasConcept C126322002 @default.
• W3161231545 hasConcept C140793950 @default.
• W3161231545 hasConcept C142724271 @default.
• W3161231545 hasConcept C143095724 @default.
• W3161231545 hasConcept C144024400 @default.
• W3161231545 hasConcept C149923435 @default.
• W3161231545 hasConcept C151956035 @default.
• W3161231545 hasConcept C156957248 @default.
• W3161231545 hasConcept C17923572 @default.
• W3161231545 hasConcept C2777843972 @default.
• W3161231545 hasConcept C2779547902 @default.
• W3161231545 hasConcept C44249647 @default.
• W3161231545 hasConcept C71924100 @default.
• W3161231545 hasConcept C86803240 @default.
• W3161231545 hasConceptScore W3161231545C126322002 @default.
• W3161231545 hasConceptScore W3161231545C140793950 @default.
• W3161231545 hasConceptScore W3161231545C142724271 @default.
• W3161231545 hasConceptScore W3161231545C143095724 @default.
• W3161231545 hasConceptScore W3161231545C144024400 @default.
• W3161231545 hasConceptScore W3161231545C149923435 @default.
• W3161231545 hasConceptScore W3161231545C151956035 @default.
• W3161231545 hasConceptScore W3161231545C156957248 @default.
• W3161231545 hasConceptScore W3161231545C17923572 @default.
• W3161231545 hasConceptScore W3161231545C2777843972 @default.
• W3161231545 hasConceptScore W3161231545C2779547902 @default.
• W3161231545 hasConceptScore W3161231545C44249647 @default.
• W3161231545 hasConceptScore W3161231545C71924100 @default.
• W3161231545 hasConceptScore W3161231545C86803240 @default.
• W3161231545 hasIssue "11" @default.
• W3161231545 hasLocation W31612315451 @default.
• W3161231545 hasLocation W31612315452 @default.
• W3161231545 hasLocation W31612315453 @default.

• next